The degree of predictivity in pilot studies on six subjects in bioequivalence trials

Pharmacological Research

Volumn 49, Issue 3, 2004, Pages 283-286

  Marzo, Antonio ^a   Fibbioli, Monia ^a   Marone, Claudio ^b   Cerutti, Bernard ^c  

^a IPAS   (United States)

^b Saint Giovanni Hospital   (Switzerland)

^c Dept of Health and Social Welfare ^*  (Switzerland)

Author keywords

Bioequivalence; Pilot trials; Pivotal trials; Predictivity index

Indexed keywords

ALPRAZOLAM; AMLODIPINE; BUTAMIRATE; CEFALEXIN; CHLORTALIDONE; FLUTAMIDE; ISOSORBIDE 5 NITRATE; NAPROXEN; NORTAMOXIFEN; TAMOXIFEN;

ARTICLE; BIOEQUIVALENCE; COMPUTER SIMULATION; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PREDICTION; PRIORITY JOURNAL;

EID: 0346690093     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phrs.2003.09.007     Document Type: Article

References (9)

1. Note for guidance on the investigation of bioavailability and bioequivalence. CPMP/EWP/QWP/1401/98; July 2001.
2. Food and Drug Administration (FDA). In vivo bioequivalence guidances. General information. United States Pharmacopoeia 1998;XXIII(Suppl. 8):4382-426.
3. Marzo A., Balant L.P. Bioequivalence: an updated reappraisal addressed to applications of interchangeable multi-source pharmaceutical products. Arzneim. Forsch. 45:1995;109-115.
4. Guidance for industry: food-effect bioavailability and bioequivalence studies. U.S. Department of Health and Human Science, FDA, Center for Drug Evaluation in Research; October 1997-BMX.
5. Note for guidance on the investigation of drug interactions. CPMP/EWP/560/95; December 17, 1997.
6. Marzo A. Open questions on bioequivalence: some problems and some solutions. Pharmacol. Res. 40:1999;357-368.
7. Marzo A., Vuksic D., Crivelli F. Bioequivalence of endogenous substances facing homeostatic equilibria: an example with potassium. Pharmacol. Res. 42:2000;523-525.
8. Racine-Poon A., Grieve A.P., Flühler H., Smith A.F.M. A two-stage procedure for bioequivalence studies. Biometrics. 43:1987;847-856.
9. Diletti E., Hauschke D., Steinijans V.W. Sample size determination for bioequivalence assessment by means of confidence intervals. Int. J. Clin. Pharmacol. Ther. Toxicol. 30(Suppl. 1):1992;S51-S58.